Risdiplam is the first potential treatment to have pivotal placebo-controlled data in a broad population of patients, including children, teenagers and adults.
News
‘Unprecedented’ study shows causes of previously unexplained cancers
Until now, previous studies just focused on the 1% of the genome that codes for proteins.
Scottish Academy launches ‘bold’ strategic priorities
The Academy of Medical Royal Colleges and Faculties in Scotland’s plan responds to the fact that the landscape of healthcare is changing considerably.
Tickets now available for the 2020 International Clinical Researcher of the Year awards ceremony
Individual tickets or tables are now available to purchase for the awards on the 14th May, taking place at the Chelsea Harbour Hotel.
London aiming to stop HIV infections for good
In January it was reported that among gay, bisexual and other men who have sex with men, the prevalence of HIV transmission has fallen by a staggering 71%.
Bayer’s Eylea proves efficacy, safety in ALTAIR study
The study evaluated two different Treat and Extend (T&E) dosing regimens in patients with wet AMD.
London Cancer Hub receives major investment
The hub has secured £8.4 million in funding.
Gilead joins GSK, J&J in offering coronavirus vaccine options
The pharma giant is offering its experimental remdesivir in the running for the optimal vaccine candidate.
Palforzia becomes first peanut allergy drug to get US approval
The approval marks a “defining moment” for the peanut allergy community.
Pharmacists ‘embracing online channels’ for wider reach
Only 7% of pharmacists believe it is not important for their pharmacy to have an online presence.
Survey reveals ‘key barriers’ limiting PCSK9is prescribing
Just 6% of cardiologists are currently prescribing PCSK9is, despite 97% believing in their abilities.
NICE to request Aimovig evidence, appeal panel rules
NICE initially rejected NHS funding for the monoclonal antibody in January last year, deeming it “too costly” for the service.
RCPE launches strategy to improve health & patient care
The “ambitious” new strategy is dubbed “Towards 2025 Together”.
UK coronavirus info campaign launched
By last Tuesday, the death toll in China stood at more than 420, and the Chinese government had reported 20,438 confirmed cases.
BMS withdraws EU Opdivo/Yervoy application
The application was initially filed in 2018 for patients with first-line NSCLC.
